Journal profile · MEDICINE, RESEARCH & EXPERIMENTAL
ALTEX-Alternatives to Animal Experimentation
ISSN 1868-596X · eISSN 1868-8551 · Springer International Publishing AG · GERMANY
ALTEX-Alternatives to Animal Experimentation: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 5.23; fully open access; APC charged, amount not published; median 127 days to acceptance (51 articles, last 24 months); community-reported acceptance: about 95%; 103 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
ALTEX-Alternatives to Animal Experimentation is published by Springer International Publishing AG and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Animal testing and alternatives, Computational Drug Discovery Methods and Effects and risks of endocrine disrupting chemicals, together about 47.2% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
ALTEX is issued by ALTEX Edition, c/o Zürcher Tierschutz, Zürichbergstrasse 263, 8044 Zurich, Switzerland ALTEX is the official organ ofCAAT - Center for Alternatives to Animal Testing, Johns Hopkins University, Baltimore, MD, USACAAT-Europe - Center for Alternatives to Animal Testing - Europe, University of Konstanz, Konstanz, GermanyDoerenkamp-Zbinden Chairs in Germany (In-vitro Toxicology and Biomedicine at the University of Konstanz), USA (Evidence-based Toxicology at the Johns Hopkins University in Baltimore) and Switzerland (Doerenkamp-Naef-Zbinden Chair for Alternative Methods at the University of Geneva), EUSAATt4 - transatlantic think tank for toxicology, Baltimore, USA, Konstanz, Germany About ALTEXThe journal Alternativen zu Tierexperimenten was first published in 1984 by the Fonds für versuchstierfreie Forschung, Zurich (FFVFF, now Animalfree Research, Berne) and ran under ISSN 1018-4562 from 1991-1993 and ISSN 0946-7785 from 1994-2008. ALTEX has been owned and issued by the society ALTEX Edition since 2006 along with the journals ALTEX Proceedings and TIERethik. The journal title was changed to ALTEX - Alternatives to Animal Experimentation in 2009 (online ISSN: 1868-8551; print ISSN: 1868-596X). The journal began open access publication of research articles in 2007 and of full content in 2013 and has been recognized as a gold open access journal by the Directory of Open Access Journals since 2013. ALTEX has endorsed the ARRIVE guidelines for reporting on animal experiments since 2011. ALTEX was awarded a Special Prize of the Fondation E. Naef pour la recherche in vitro in 2003 and was recognized by a commendation in the category “Public Awareness” by the LUSH Prize in 2016. The best article published in the preceding year in the journal is awarded the annual ALTEX Award. ALTEX currently publishes four issues per year. Journal content is archived in the PKP Preservation Network (PKP-PN) and in CLOCKSS. Open access policyALTEX is an open access journal, which means that all content is freely available without charge. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles in this journal without asking prior permission from the publisher or the author. Articles are distributed under the terms of the Creative Commons Attribution 4.0 International license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium, provided the o
From the journal's Aims & Scope
Research area (LetPub): MEDICINE, RESEARCH & EXPERIMENTAL
Main research topics OpenAlex counts of recent articles; shares are approximate
- Animal testing and alternativesVeterinary27.3%
- Computational Drug Discovery MethodsComputer Science10.3%
- Effects and risks of endocrine disrupting chemicalsEnvironmental Science9.6%
- 3D Printing in Biomedical ResearchEngineering7%
- Contact Dermatitis and AllergiesMedicine5.2%
- Agricultural safety and regulationsAgricultural and Biological Sciences4.1%
- Pluripotent Stem Cells ResearchBiochemistry, Genetics and Molecular Biology3.4%
- Carcinogens and Genotoxicity AssessmentBiochemistry, Genetics and Molecular Biology3.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Medicine, Research & Experimental | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Medicine, Research & Experimental | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Medicine, Research & Experimental | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 5.23LetPub ·
- 5-year impact factor (publisher)
- 5.5Publisher website ·
- CiteScore 2026-06
- 8.9LetPub ·
- SJR 2026-06
- 1.1LetPub ·
- SNIP 2026-06
- 1.18LetPub ·
- h-index
- 78OpenAlex ·
- i10-index
- 467OpenAlex ·
- 2-year mean citedness
- 2.06OpenAlex ·
- Self-citation rate
- 18.2%LetPub ·
- Share of gold OA articles
- 98.36%LetPub ·
Volume
- Articles per year
- 42LetPub ·
Articles by year OpenAlex count · 1,251 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 64 | 64 | 69 |
| 2025 | 103 | 103 | 184 |
| 2024 | 83 | 83 | 261 |
| 2023 | 82 | 82 | 468 |
| 2022 | 107 | 107 | 933 |
| 2021 | 76 | 76 | 740 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
127 daysMedian, submission to acceptance · P25–P75 90 days – 187 days
- Acceptance to online
- median 9 days (54 articles)
- Submission to online
- median 135 days
- Sample
- 51 articles with submission and acceptance dates (108 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 2 monthsLetPub ·
- Average acceptance (community reports)
- 95%LetPub ·
- Submission to publication (journal-reported)
- about 18 weeksDOAJ ·
- Peer review
- Single anonymous peer review, Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | EUR 2,500 | Yes | CC BY | |
| OpenAlex | EUR 2,000 | — | — | |
| LetPub | EUR 2,000 | Yes | — | |
| Publisher website | EUR 2,500 / EUR 1,300 / EUR 400 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted2
- letterLetters very briefly alert readers to important developments or findings in the field of 3Rs research. They should be no longer than 1 page (single spaced, 9pt …Length not stated
- short communicationA short communication is a brief research report on no more than 4 printed pages of text (single spaced, 9 pt) with no more than 1 page of figures or tables. Re…Length not stated
Policy excerpts from the journal's websiteLicense & copyright
- License & copyright Copyright Notice
Articles are distributed under the terms of the Creative Commons Attribution 4.0 International license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium, provided the original work is appropriately cited (CC-BY). Copyright on any article in ALTEX is retained by the author(s).
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer International Publishing AG
- Country or region
- GERMANY
- Language
- English
- ISSN
- 1868-596X
- Electronic ISSN
- 1868-8551
- Society / sponsor
- CAAT
- Latest issue on the website
- Volume 43, Issue 3 (2026)
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about ALTEX-Alternatives to Animal Experimentation
What CAS zone is ALTEX-Alternatives to Animal Experimentation in?
In the 2025 upgraded edition of the CAS Journal Ranking, ALTEX-Alternatives to Animal Experimentation is in Zone 2 of Medicine, and in Zone 3 of the minor category Medicine, Research & Experimental. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of ALTEX-Alternatives to Animal Experimentation?
The latest impact factor listed by LetPub is 5.23; CiteScore 8.9, h-index 78.
How long does peer review take at ALTEX-Alternatives to Animal Experimentation?
Based on the dates recorded on 51 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 127 days (interquartile range 90–187 days); authors report an average review time of about 2 months; the community-reported acceptance is “about 95%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index ALTEX-Alternatives to Animal Experimentation?
According to LetPub and DOAJ records, ALTEX-Alternatives to Animal Experimentation is indexed in SCIE, Scopus and DOAJ.
Is ALTEX-Alternatives to Animal Experimentation open access, and what is the APC?
ALTEX-Alternatives to Animal Experimentation is a fully open-access journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .